Prochlorperazine is primarily used to treat severe nausea and vomiting, but it also has approved uses for vertigo, certain psychiatric conditions, and short-term anxiety. It belongs to a class of older medications called phenothiazines and works by blocking dopamine receptors in the part of the brain that triggers the vomiting reflex. It typically starts working within 30 to 60 minutes of taking it.
Nausea and Vomiting
The most common reason people are prescribed prochlorperazine is to control severe nausea and vomiting. This includes nausea caused by surgery, medications (such as chemotherapy), migraines, and various other conditions. It works by blocking chemical signals in a structure called the chemoreceptor trigger zone, which is the brain’s main “nausea center.” When dopamine and other chemical messengers activate this area, you feel the urge to vomit. Prochlorperazine blocks those signals before they can take hold.
For nausea, the typical oral dose is 5 to 10 mg taken three or four times daily, with a usual ceiling of 40 mg per day. Most people notice relief within 30 to 60 minutes of swallowing a tablet. It can also be given as a suppository or injection when vomiting makes swallowing a pill impractical.
Vertigo and Balance Disorders
Prochlorperazine is widely prescribed for vertigo, the sensation that the room is spinning around you. It acts on the neural pathways connected to the inner ear’s balance system, calming the misfiring signals responsible for dizziness. This makes it useful for conditions like Ménière’s disease and other inner-ear (vestibular) disorders. For Ménière’s disease specifically, it may take a few days of regular use before the full benefit kicks in, unlike the faster relief seen with nausea.
Psychiatric Conditions
Although prochlorperazine is best known as an anti-nausea drug, it is also approved for two psychiatric uses: schizophrenia and other psychotic disorders, and short-term, non-psychotic anxiety.
Schizophrenia and Psychosis
In milder outpatient cases, the starting dose for psychotic disorders is typically 5 to 10 mg three or four times a day. For more severe episodes in supervised settings, doses can be increased gradually, with some patients responding to 50 to 75 mg daily and others requiring 100 to 150 mg daily. Because newer antipsychotics generally carry fewer neurological side effects, prochlorperazine is not a first-line choice for most psychiatric conditions today, but it remains an approved option.
Short-Term Anxiety
For anxiety that is not related to a psychotic disorder, prochlorperazine can be used at lower doses (5 mg three or four times daily). There is a strict limit here: no more than 20 mg per day, and no longer than 12 weeks. Beyond that window, the risk of a serious movement side effect called tardive dyskinesia rises significantly, and the potential harm outweighs the benefit for a non-psychotic condition.
How It Works in the Body
Prochlorperazine is classified as both a central and peripheral dopamine blocker. That means it reduces dopamine activity in the brain and elsewhere in the body. But dopamine is not its only target. It also blocks receptors for acetylcholine (involved in memory and muscle control) and serotonin (involved in mood and gut function), which helps explain its broad anti-nausea effect. Additionally, it has some activity blocking adrenaline-related receptors, which can cause side effects like low blood pressure or drowsiness.
Common Side Effects
Because prochlorperazine interferes with dopamine, a brain chemical that also controls movement, many of its side effects involve the muscles and nervous system. These are sometimes grouped under the term “extrapyramidal symptoms,” and they show up in a significant number of people, particularly at higher doses used for psychiatric conditions.
The most common patterns include:
- Muscle spasms (dystonia): Abnormal, sustained muscle contractions that tend to appear in the first few days of treatment. These can affect the neck, throat, and tongue, sometimes making swallowing or breathing feel difficult.
- Restlessness: A jittery, agitated feeling where you may find it hard to sit still. Insomnia can accompany it.
- Parkinsonism-like symptoms: Tremors, stiff movements, a shuffling walk, drooling, or a flat facial expression. These mimic Parkinson’s disease because both involve reduced dopamine signaling.
Drowsiness and impaired thinking are also common, especially during the first few days. Prochlorperazine can impair both mental and physical abilities, so driving or operating machinery may not be safe until you know how it affects you.
Serious Risks to Be Aware Of
Two serious risks stand out with prochlorperazine, both tied to how long and how much you take.
The first is tardive dyskinesia: involuntary, repetitive movements of the face, tongue, or limbs that can become permanent. The risk increases with longer use and higher total doses over time, though it can occasionally appear even after short courses at low doses. There is no reliable treatment for tardive dyskinesia once it develops, although stopping the medication sometimes leads to partial or complete improvement.
The second is neuroleptic malignant syndrome, a rare but potentially fatal reaction. Signs include a very high fever, severe muscle rigidity, confusion, an unstable heart rate, and heavy sweating. This is a medical emergency.
Prochlorperazine also carries a boxed warning (the FDA’s most serious label warning) regarding elderly patients with dementia-related psychosis. Clinical trials of antipsychotic medications in this population found a death rate of about 4.5% over 10 weeks, compared to 2.6% for those on placebo. Most deaths were cardiovascular or infection-related. Prochlorperazine is not approved for treating dementia-related psychosis.
Use in Children
Prochlorperazine is approved for children ages 2 and older, both for severe nausea and for schizophrenia. Doses are significantly lower than adult doses and are adjusted by age. For children ages 2 to 5, the total daily dose typically stays under 20 mg. For children ages 6 to 12, the ceiling is generally 25 mg per day. Children are more susceptible to the movement-related side effects described above, so the lowest effective dose is used for the shortest time needed.